Shelton Capital Management Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Shelton Capital Management boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 73,628 shares of the medical equipment provider's stock after purchasing an additional 5,490 shares during the quarter. Intuitive Surgical comprises 1.0% of Shelton Capital Management's holdings, making the stock its 12th largest holding. Shelton Capital Management's holdings in Intuitive Surgical were worth $38,431,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Invesco Ltd. grew its stake in shares of Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after buying an additional 295,025 shares during the period. Employees Retirement System of Texas increased its holdings in shares of Intuitive Surgical by 16.2% during the fourth quarter. Employees Retirement System of Texas now owns 8,346 shares of the medical equipment provider's stock valued at $4,356,000 after acquiring an additional 1,165 shares in the last quarter. Cerity Partners LLC increased its holdings in shares of Intuitive Surgical by 16.7% during the fourth quarter. Cerity Partners LLC now owns 162,397 shares of the medical equipment provider's stock valued at $84,209,000 after acquiring an additional 23,222 shares in the last quarter. Trek Financial LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $4,104,000. Finally, Alcosta Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth $4,891,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of the company's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $4.08 during trading hours on Friday, hitting $493.60. The company had a trading volume of 2,842,153 shares, compared to its average volume of 1,600,352. The firm has a market capitalization of $175.81 billion, a price-to-earnings ratio of 77.00, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a 50 day simple moving average of $532.72 and a 200 day simple moving average of $532.68.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Piper Sandler restated an "overweight" rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Leerink Partners raised their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.